FDA Investigator Ramon E Martinez

Ramon E Martinez has conducted inspections on 55 sites in 4 countries as of 16 Jul 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
55
Last Inspection Date:
16 Jul 2014
Investigator Role:
FDA Investigator
Redica ID:
100005847
Countries of Inspections:
United States of America, France, Denmark, India
FDA Investigators that have inspected at least one site in common with Ramon E Martinez:
Abdur Rafay Shareef, Aireen V Mendoza, Alan R Condon, Alice C Silva, Alla Kachko, PhD, Allison A Aldridge, PhD, Allison A Rodriguez, Almaris N Alonso, Amber G Wardwell, Amy C Jordan, Anastasia I Offordile, Andrew M Barlow, Angela E Glenn, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anne Marie Dubrey, Anthony C Warchut, Anthony W Thomas, Arie C Menachem, Ashley J Burns, Ashley M Whitehurst, Audrey Thereset Uy, Bo Chi, PhD, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brentley S Collins, Brian S Keefer, Byungja E Marciante, Camerson E Moore, Candace Y Gomez Broughton, Carla J Lundi, Carlos Chavez, Cassandra L Abellard, Catherine J Laufmann, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Charisse K Green, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Christian D Lynch (CDL), Christina J Sauder, PhD, Christine L Williams, Christopher J Adams, Christopher Janik, Constance Desimone, Courtney N Long, Craig D Zagata, Cynthia Jim, CSO, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, Dave Hafner, David J Hafner, David P Vanhouten, Debra J Bennett, Debra L Pagano, Dell S Moller, Demitria J Xiradakis, Dennis Cantellops Paite, Devaughn Edwards, Dien N Nguyen, Dolores Harper, Donald C Obenhuber, PhD, Donna J Clevenger, Dorothy W Lee, Douglas A Campbell, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Eileen A Liu, Elizabeth Ll Edwards, Ellen Huang, Ellen P Madigan, Erin P Conlin, Felix Maldonado, Frank P Hurst, Frederick F Razzaghi, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Ginger M Sykes, Hala L Selby, Haley H Seymour, Haruhiko Murata, Helen B Ricalde, Holly Brevig, J David Doleski, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James M Mason, James W Whitney, Jason A Rossi, Jawaid Hamid, Jayaleka J Amarasinghe, Jeremy W Rotton, Jianming Li, Joan A Loreng, Joan Adamo, Joanne E King, Joanne M Hajoway, John A Sciacchitano, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Lopez, Jose Acruz Gonzalez, Jose Ohernandez Guzman, Joseph A Piechocki, Joseph George, Joseph H Procopio, Jr, Joyce A Kellett, Juanita P Versace, Jude C Dikes, Julianne C Mccullough, Julie A Finegan, June P Page, Junho Pak, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Karyn M Campbell, Katherine D Adams, Kathleen B Mihalik, Kathryn Carbone, MD, Kathy E Craven, Kathy E Noe, Katie L Korchinski, Kelly N Kerr, Kenneth H Williams, Kenneth M Gordon, Kent A Conforti, Kevin A Gonzalez, Kristen D Evans, Kristina J Donohue, L Norwood, Laura Fontan, MS, Lauren M Lawrance, Laurie B Frazier, Laurie Graham, Lawton W Lum, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Margaret Edi Gennaro, Leo B Zadecky, Lewis K Antwi, Linda Thai, Lisa M Bellows, Lisa M Feola, Lori A Holmquist, Lori M Newman, LT John M Mastalski, Lydia I Rosas Marty, Lydia S Chan, M Pedgen, Margaret E Walsh, Margaret M Sands, Marian E Major, PhD, Marion Michaelis, Mariza M Jafary, Mark E Parmon, Mark R Mcclain, Marlene G Swider, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Matthew D Silverman, Maura Rooney, Maya M Davis, Megan A Haggerty, Michael A Charles, Michael Curbarg, Michael Gurbarg, Michael J Casey, Michael P Anthony, Michael P Sheehan, Michael P Sweeney, Michael Serrano, Michele Perry Williams, Michelle M Noe Varga, Michelle Yclark Stuart, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Minh D Phan, Monique C Lo, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nealie C Newberger, Nicholas A Violand, Nichole B Murphy, Nicole E Knowlton, Nicole K Trudel, Obinna R Echeozo, Omotunde O Osunsanmi, Osama A Khatib, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia F Hughes, PhD, Paul L Bellamy, Paul P Geraci, Paula A Trost, Pei I Chu, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Priscilla M Pastrana, Rachael O Oyewole, Raeann R Wu, Rajiv R Srivastava, Ralph H Vocque, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca E Dombrowski, Rebecca K Olin, Richard H Penta, Richard L Friedman, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Martin, Robert O'brian, Rory K Geyer, Rose Ashley, Satheesh Thomas, Scott B Laufenberg, Scott C Lute, Scott E Norris, Scott R Nichols, PhD, Scott T Ballard, Sean R Marcsisin, Sergey S Akimov, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Shirley J Berryman, Shuang Tang, Simone E Pitts, Sixto M Mercado Rios, Slater K Bartlett, Stacey S Degarmo, Stefan Kaszycki, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen D Brown, Stephen D Eich, Stephen R Souza, Steven A Rubin, Steven B Hertz, Steven Fong, MS, PhD, Steven M Weinman, Sunita Pandey, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan T Hadman, Susanne M Richardson, MS RAC, Suzanne M Healy, Svetlana A Shestopal, Tamil Arasu, PhD, Tammy L Chavis, Teddy Tom, Teresa I Navas, Theresa M To, Thomas J Arista, Thomas Siebertz, Thomas W Nerney, Timothy M Glod, Tina S Roecklein, Towanda L Terrell, Troy R Petrillo, Unnee Ranjan, Valentino Fiorella, Vijaya L Simhadri, Vlada Matusovsky, Wayne E Seifert, Wei Wang, PhD, Wendy A Johnecheck, William J Leonard, William K Dagley, William S Boivin, Xiao Wang, Xiaokuang Lai, PhD, Xiaoping Guan, Yehualashet A Gessesse, Ying Xin Fan, PhD, Yumi J Hiramine, Zhichao Lin, Zhongren Wu

Ramon E Martinez's Documents

Publish Date Document Type Title
October, 2008 FDA 483 Response AMAG Pharmaceuticals, Inc. - Form 483R, 2008-11-03
December, 2013 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2013-12-11
December, 2011 FDA 483 Millennium Pharmaceuticals, Inc. - Form 483, 2011-12-16
May, 2013 FDA 483 Cipla Ltd. - Form 483, 2013-05-30
October, 2008 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2008-10-22
March, 2012 EIR Novo Nordisk A/S - EIR, 2012-03-20
November, 2012 FDA 483 Ameridose, LLC - Form 483, 2012-11-09
January, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-01-29
October, 2010 FDA 483 Formatech Inc. - Form 483, 2010-10-15
March, 2012 FDA 483 Novo Nordisk A/S - Form 483, 2012-03-20
September, 2013 FDA 483 Lonza Biologics, Inc. - Form 483, 2013-09-30
August, 2011 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2011-08-11
August, 2009 FDA 483 Shamrock Medical Solutions Group LLC - Form 483, 2009-08-11
September, 2013 EIR Lonza Biologics, Inc. - EIR, 2013-09-30
July, 2013 FDA 483 Lyophilization Services of New England, Inc. - Form 483, 2013-07-31
May, 2014 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2014-05-21
May, 2014 EIR AMAG Pharmaceuticals, Inc. - EIR, 2014-05-21
August, 2014 FDA 483 Johnson Memorial Cancer Center - Form 483, 2014-08-05
August, 2010 FDA 483 Fresenius Medical Care Holdings, Inc. - Form 483, 2010-08-06
February, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-02-19
January, 2012 FDA 483 Shire Human Genetics Therapies, Inc. - Form 483, 2012-01-11
February, 2011 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2011-02-18
January, 2010 FDA 483 Braintree Laboratories, Inc. - Form 483, 2010-01-22
October, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-10-22
April, 2011 FDA 483 AstraZeneca LP - Form 483, 2011-04-27
July, 2014 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2014-07-10
December, 2008 FDA 483 Genzyme Corporation - Form 483, 2008-12-05
July, 2009 FDA 483 The Dodge Company, Inc. - Form 483, 2009-07-02
April, 2010 FDA 483 Curia Massachusetts, Inc. - Form 483, 2010-04-01
June, 2009 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2009-06-18
October, 2011 FDA 483 Genzyme Corporation - Form 483, 2011-10-27
April, 2013 FDA 483 Pallimed Solutions, Inc. - Form 483, 2013-04-09
May, 2012 FDA 483 ALK-ABELLO, INC. - Form 483, 2012-05-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more